D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 73 Citations 76,263 389 World Ranking 13514 National Ranking 72

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Myocardial infarction

His primary areas of study are Internal medicine, Cardiology, Atrial fibrillation, Heart failure and Stroke. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Surgery. His Cardiology study frequently draws connections between related disciplines such as Hazard ratio.

His Heart failure research incorporates elements of Adverse effect, Heart disease and Intensive care medicine. His work deals with themes such as Anticoagulant, Anesthesia and Gastrointestinal bleeding, which intersect with Stroke. The various areas that Dan Atar examines in his Management of atrial fibrillation study include Cardioversion, Medical emergency, HAS-BLED and Catheter ablation.

His most cited work include:

  • Apixaban versus Warfarin in Patients with Atrial Fibrillation (5705 citations)
  • ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation (5547 citations)
  • 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (3899 citations)

What are the main themes of his work throughout his whole career to date?

Dan Atar mainly focuses on Internal medicine, Cardiology, Myocardial infarction, Heart failure and Atrial fibrillation. His Internal medicine study frequently intersects with other fields, such as Surgery. His studies in Cardiology integrate themes in fields like Clinical trial and Hazard ratio.

His Myocardial infarction research is multidisciplinary, incorporating perspectives in Reperfusion injury and Randomized controlled trial. As part of the same scientific family, he usually focuses on Heart failure, concentrating on Intensive care medicine and intersecting with MEDLINE. His biological study spans a wide range of topics, including Diabetes mellitus and Proportional hazards model.

He most often published in these fields:

  • Internal medicine (77.46%)
  • Cardiology (57.01%)
  • Myocardial infarction (23.30%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (77.46%)
  • Cardiology (57.01%)
  • Atrial fibrillation (22.35%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Internal medicine, Cardiology, Atrial fibrillation, Heart failure and Myocardial infarction. In his study, Cardioversion is strongly linked to Diabetes mellitus, which falls under the umbrella field of Internal medicine. In general Cardiology study, his work on Percutaneous coronary intervention often relates to the realm of Risk assessment, thereby connecting several areas of interest.

Dan Atar has included themes like Stroke, Cryptogenic stroke and MEDLINE in his Atrial fibrillation study. His Heart failure research incorporates themes from Clinical trial, Ivabradine, Emergency medicine, Proportional hazards model and Prospective cohort study. In general Myocardial infarction, his work in Reperfusion therapy and Revascularization is often linked to Norwegian linking many areas of study.

Between 2018 and 2021, his most popular works were:

  • Efficacy and Safety of Apixaban versus Warfarin in Patients with Atrial Fibrillation and Extremes in Body Weight:Insights from the ARISTOTLE Trial (35 citations)
  • Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis. (27 citations)
  • Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis. (27 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Myocardial infarction

Dan Atar mainly investigates Internal medicine, Cardiology, Heart failure, Myocardial infarction and Stroke. Many of his research projects under Internal medicine are closely connected to In patient and Brainstorming with In patient and Brainstorming, tying the diverse disciplines of science together. His studies deal with areas such as Cancer and Subspecialty as well as Cardiology.

His research integrates issues of Fibrinolysis, Randomized controlled trial, Pathophysiology and Myocardial tissue in his study of Myocardial infarction. The Stroke study combines topics in areas such as Pharmacotherapy and Atrial fibrillation. Dan Atar has researched Atrial fibrillation in several fields, including CHA2DS2–VASc score and Intermediate risk.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation

Stefan K. James;Dan Atar;Luigi P. Badano;Carina Blomstrom Lundqvist.
European Heart Journal (2012)

8910 Citations

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Paulus Kirchhof;Stefano Benussi;Dipak Kotecha;Anders Ahlsson.
Europace (2016)

8635 Citations

Apixaban versus Warfarin in Patients with Atrial Fibrillation

Christopher B. Granger;John H. Alexander;Renato D. Lopes;Elaine M. Hylek.
The New England Journal of Medicine (2011)

8527 Citations

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO)

Kirchhof P;Benussi S;Kotecha D;Ahlsson A.
European Heart Journal (2016)

6258 Citations

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

A. John Camm;Gregory Y.H. Lip.
European Heart Journal (2012)

4255 Citations

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008

Kenneth Dickstein;Alain Cohen-Solal;Gerasimos Filippatos;John J V McMurray.
European Journal of Heart Failure (2008)

2484 Citations

Guidelines for the management of atrial fibrillation

A. John Camm;Paulus Kirchhof;Gregory Y H Lip;Ulrich Schotten.
Europace (2010)

1947 Citations

Effect of nesiritide in patients with acute decompensated heart failure.

C. M. O'Connor;R. C. Starling;A. F. Hernandez;P. W. Armstrong.
The New England Journal of Medicine (2011)

1237 Citations

Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

John H. Jh Alexander;RD D Renato D. Rd Renato D Lopes;Stefan James;Rakhi Kilaru.
The New England Journal of Medicine (2011)

1169 Citations

2012 Focused Update of the ESC Guidelines for the Management of Atrial Fibrillation

A. John Camm;Gregory Y.H. Lip;Raffaele De Caterina;Irene Savelieva.
Revista Espanola De Cardiologia (2013)

1044 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Dan Atar

Gregory Y.H. Lip

Gregory Y.H. Lip

University of Liverpool

Publications: 1148

Paulus Kirchhof

Paulus Kirchhof

University of Birmingham

Publications: 215

Renato D. Lopes

Renato D. Lopes

Duke University

Publications: 173

John W. Eikelboom

John W. Eikelboom

Population Health Research Institute

Publications: 147

Lars Wallentin

Lars Wallentin

Uppsala University

Publications: 146

Christopher B. Granger

Christopher B. Granger

Duke University

Publications: 142

Deirdre A. Lane

Deirdre A. Lane

University of Liverpool

Publications: 142

Gunnar H. Gislason

Gunnar H. Gislason

National Heart Foundation of Australia

Publications: 142

John J.V. McMurray

John J.V. McMurray

University of Glasgow

Publications: 141

Marco Metra

Marco Metra

University of Brescia

Publications: 138

Giuseppe Boriani

Giuseppe Boriani

University of Modena and Reggio Emilia

Publications: 127

Gregg C. Fonarow

Gregg C. Fonarow

University of California, Los Angeles

Publications: 126

Jonathan P. Piccini

Jonathan P. Piccini

Duke University

Publications: 122

Deepak L. Bhatt

Deepak L. Bhatt

Brigham and Women's Hospital

Publications: 121

Gerhard Hindricks

Gerhard Hindricks

Leipzig University

Publications: 119

Aldo P. Maggioni

Aldo P. Maggioni

Heart Care Foundation, ANMCO Research Center, Florence

Publications: 116

Something went wrong. Please try again later.